NKTR- Nektar Therapeutics

Name: Nektar Therapeutics Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Robin Howard W	75.9K	$5.06M	-
Other	Wilson Mark Andrew	21.6K	$1.44M	-
Other	Zalevsky Jonathan	15.4K	$1.03M	-5,538
Dir	Ajer Jeffrey Robert	8.0K	$533.5K	-
Dir	Greer R Scott	8.0K	$533.5K	-

Activity

Buys and sells only

Transactions

10 filings · page 18

Date	Insider	Role	Type	Shares	Price	Value	Chg%
May 16, 2019	Nicholson John	SVP &Chief Operating Officer	Sell	4,077	$31.37	$127,895.49	-2.4%
May 16, 2019	Labrucherie Gil M84	SVP &Chief Financial Officer	Sell	3,767	$31.37	$118,170.79	-2.9%
May 16, 2019	Hora Maninder	SVP Pharma Dev &Mfg Ops	Sell	2,449	$31.37	$76,825.13	-2.5%
May 16, 2019	Doberstein Stephen K	SVP &Chief Scientific Officer	Sell	3,461	$31.37	$108,571.57	-3.5%
Feb 21, 2019	Robin Howard W58	President &CEO	Sale+OE	108,882	$42.19	$4,594,175.67	-8.0%
Feb 19, 2019	Thomsen Jillian B.86	SVP &Chief Accounting Officer	Sell	1,808	$42.39	$76,641.12	-1.1%
Feb 19, 2019	Nicholson John	SVP &Chief Operating Officer	Sell	3,822	$42.39	$162,014.58	-2.2%
Feb 19, 2019	Labrucherie Gil M84	SVP &Chief Financial Officer	Sell	3,592	$42.39	$152,264.88	-2.7%
Feb 19, 2019	Hora Maninder	SVP Pharma Dev &Mfg Ops	Sell	2,386	$42.39	$101,142.54	-2.4%
Feb 19, 2019	Doberstein Stephen K	SVP &Chief Scientific Officer	Sell	3,310	$42.39	$140,310.90	-3.2%

← PrevPage 18Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC